Citius Pharmaceuticals Inc. (NASDAQ:CTXR) went up by 32.05% from its latest closing price compared to the recent 1-year high of $1.97. The company’s stock price has collected 51.47% of gains in the last five trading sessions. Press Release reported on 02/19/21 that Citius Pharmaceuticals Announces Closing of $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Is It Worth Investing in Citius Pharmaceuticals Inc. (NASDAQ :CTXR) Right Now?
Plus, the 36-month beta value for CTXR is at 1.58. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Citius Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $8.00. CTXR currently public float of 56.83M and currently shorts hold a 4.26% ratio of that float. Today, the average trading volume of CTXR was 6.64M shares.
CTXR’s Market Performance
CTXR stocks went up by 51.47% for the week, with a monthly jump of 55.47% and a quarterly performance of 120.39%, while its annual performance rate touched 146.15%. The volatility ratio for the week stands at 15.36% while the volatility levels for the past 30 days are set at 12.50% for Citius Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is 54.08% for CTXR stocks with a simple moving average of 90.10% for the last 200 days.
CTXR Trading at 71.28% from the 50-Day Moving Average
After a stumble in the market that brought CTXR to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 4.57% of gains for the given period.
Volatility was left at 12.50%, however, over the last 30 days, the volatility rate increased by 15.36%, as shares surge +64.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +79.13% upper at present.
During the last 5 trading sessions, CTXR rose by +51.47%, which changed the moving average for the period of 200-days by +128.94% in comparison to the 20-day moving average, which settled at $1.38. In addition, Citius Pharmaceuticals Inc. saw 101.96% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CTXR
The total capital return value is set at -59.46, while invested capital returns managed to touch -59.42. Equity return is now at value -77.70, with -59.40 for asset returns.
Based on Citius Pharmaceuticals Inc. (CTXR), the company’s capital structure generated 4.02 points at debt to equity in total, while total debt to capital is 3.86. Total debt to assets is 3.09, with long-term debt to equity ratio resting at 3.03. Finally, the long-term debt to capital ratio is 2.91.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.